tiprankstipranks
Phibro Animal Health (PAHC)
NASDAQ:PAHC
US Market

Phibro Animal Health (PAHC) Earnings Dates, Call Summary & Reports

Compare
82 Followers

Earnings Data

Report Date
May 07, 2025
TBA Not Confirmed
Period Ending
2025 (Q3)
Consensus EPS Forecast
0.53
Last Year’s EPS
0.31
Same Quarter Last Year
Moderate Sell
Based on 4 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Feb 05, 2025
|
% Change Since: 2.68%
|
Next Earnings Date:May 07, 2025
Earnings Call Sentiment|Positive
The earnings call highlighted strong financial performance driven by the successful integration of the Zoetis MFA portfolio and robust growth in the animal health segment. However, challenges such as increased SG&A costs, integration hurdles, and broader industry factors like emerging diseases and tariffs were noted. Overall, the positive aspects, particularly the updated guidance and strategic initiatives, outweigh the challenges.
Company Guidance
During the Phibro Animal Health Corporation's earnings call, the company provided updated guidance for fiscal year 2025, anticipating total net sales between $1.25 billion to $1.3 billion, representing a growth range of 23% to 28%. The guidance reflects the integration of the Zoetis medicated feed additive portfolio and the benefits from the Phibro Forward income growth initiative. Phibro projects total adjusted EBITDA to range from $172 million to $180 million, marking a growth range of 55% to 62%, with adjusted net income estimated between $76 million to $82 million, indicating growth of 57% to 70%. The expected total adjusted diluted EPS is between $1.87 and $2.01, reflecting an improvement of 57% to 69%. These projections include early benefits from the Phibro Forward initiative aimed at revenue growth and cost savings, while excluding significant headcount reductions.
Strong Financial Performance
Consolidated net sales increased by 24% to $309.3 million. Adjusted EBITDA surged 64% to $18.7 million, demonstrating strong demand in the animal health business and contributions from the Zoetis MFA portfolio.
Animal Health Segment Growth
Animal health segment sales grew by 33% to $229.4 million. Legacy MFA and other product sales increased by 11%, vaccines expanded by 12%, and nutritional specialties rose by 11%.
Zoetis MFA Integration Success
Successful integration of the Zoetis medicated feed additive portfolio with two months of contributions amounting to $36.7 million in sales, driving overall MFA growth to 47%.
Updated Guidance Reflects Growth
Updated fiscal year 2025 guidance includes net sales of $1.25 billion to $1.3 billion, reflecting growth of 23% to 28%. Total adjusted EBITDA is expected to grow by 55% to 62%.
Operational Excellence and Strategic Initiatives
Phibro Forward initiative continues to drive operational excellence with focus on strategic innovation, targeted portfolio expansion, and disciplined financial management.
---

Phibro Animal Health (PAHC) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

PAHC Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 07, 20252025 (Q3)
0.53 / -
0.31
Feb 05, 20252025 (Q2)
0.42 / 0.54
0.3363.64% (+0.21)
Nov 06, 20242025 (Q1)
0.25 / 0.35
0.14150.00% (+0.21)
Aug 28, 20242024 (Q4)
0.33 / 0.41
0.387.89% (+0.03)
May 08, 20242024 (Q3)
0.29 / 0.31
0.296.90% (+0.02)
Feb 07, 20242024 (Q2)
0.28 / 0.33
0.34-2.94% (-0.01)
Nov 08, 20232024 (Q1)
0.23 / 0.14
0.21-33.33% (-0.07)
Aug 30, 20232023 (Q4)
0.37 / 0.38
0.365.56% (+0.02)
May 03, 20232023 (Q3)
0.34 / 0.29
0.33-12.12% (-0.04)
Feb 08, 20232023 (Q2)
0.30 / 0.34
0.37-8.11% (-0.03)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

PAHC Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 05, 2025$22.37$24.58+9.88%
Nov 06, 2024$23.09$23.50+1.78%
Aug 28, 2024$20.68$21.34+3.19%
May 08, 2024$16.96$17.47+3.01%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Phibro Animal Health (PAHC) report earnings?
Phibro Animal Health (PAHC) is schdueled to report earning on May 07, 2025, TBA Not Confirmed.
    What is Phibro Animal Health (PAHC) earnings time?
    Phibro Animal Health (PAHC) earnings time is at May 07, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is PAHC EPS forecast?
          PAHC EPS forecast for the fiscal quarter 2025 (Q3) is 0.53.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis